Skip to main content

Amedisys Value Stock - Dividend - Research Selection


ISIN: US0234361089, WKN: 915582

Market price date: 28.05.2021
Market price: 258,37 USD

Amedisys Fundamental data and company key figures of the share

Annual reports in USD
Key figures 01-03-2021
Cash flow
Net operating cash flow 288.952.000
Capital Expenditures -5.332.000
Free cash flow 283.620.000
Balance sheet
Total Equity 809.224.000
Liabilities & Shareholders equity 1.567.200.000
Income statement
Net income 183.608.000
Eps (diluted) 5,595
Diluted shares outstanding 32.814.300
Net sales/revenue 2.071.520.000

Fundamental ratios calculated on: 28-05-2021

Key figures 28-05-2021
Cash flow
P/C 29,34
P/FC 29,89
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization8.478.230.528,00 USD
IndicesNASDAQ Comp.
Raw Data SourceUS GAAP in Millionen USD
Stock Split2006-12-06,4.0000/3.0000; 2006-12-05,4.0000/3.0000

Description of the company

Amedisys, Inc. (Amedisys) is a provider of home health and hospice services. The Company offers home health services to the chronic, co-morbid, aging American population. The Company operates through three segments: home health, hospice and personal care. The Company's home health segment delivers a range of services in the homes of individuals recovering from surgery, have a chronic disability or terminal illness or need assistance with completing important personal tasks. The Company's hospice segment provides palliative care and comfort to terminally ill patients and their families. The Company's personal care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 330 Medicare-certified home healthcare centers, over 80 Medicare-certified hospice care centers and approximately nine personal-care care centers in over 30 states within the United States, the District of Columbia and Puerto Rico.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,